Two biotechs launch pub­lic of­fer­ings; Vaxxin­i­ty shares safe­ty da­ta on its Parkin­son's vac­cine

Two biotechs are turn­ing to pub­lic of­fer­ings to get more cash.

Cal­i­for­nia-based IGM Bio­sciences will be sell­ing some of its stock …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.